26 February 15 | The Straits Times by JACQUELINE WOO
JAPANESE drug giant Takeda Pharmaceutical Co has moved to a new central office in Biopolis to consolidate and streamline its operations in Singapore.
Its new office, about 14,000 sq ft, houses the headquarters of its emerging markets business unit - previously based in Zurich - its regional research and development centre and vaccine business unit.
Takeda's previous premises in Singapore were in...
29 January 15 | The Business Times by LEE MEIXIAN
SingaporeJAPANESE drug maker Chugai Pharmaceutical on Wednesday announced that it will invest S$476 million from now until 2021 into its research institute in Singapore, Chugai Pharmabody Research (CPR).When CPR first set up its corporate laboratory here in 2012 to develop antibody drugs, it planned to pour about S$200 million into antibody research over the subsequent five years.The new grant...
29 January 15 | The Straits Times by REME AHMAD ASSISTANT MONEY EDITOR
JAPAN'S Chugai Pharmaceutical will invest $476 million over the next seven years to expand its research institute here.
The investment will make the centre at Biopolis one of the biggest pharmaceutical research and development operations in Singapore.
It will also "significantly boost the company's local employee base and antibody research and development pipeline", said Chugai Pharmaceutical,...